Akums Drugs & Pharma appoints Yuvraj Datta as President - Operational Strategy & Excellence

Written By : Ruchika Sharma Published On 2025-11-30T12:45:26+05:30 | Updated On 30 Nov 2025 12:45 PM IST

New Delhi: Akums Drugs & Pharma has appointed Yuvraj Datta as its new President - Operational Strategy & Excellence.

Datta shared the update through a LinkedIn post, writing, "I’m happy to share that I’m starting a new position as President - Operational Strategy & Excellence at Akums Drugs & Pharmaceuticals Ltd!"

Alongside his new role at Akums, Datta also serves as a Board Advisor at BlueLotus Value Tradelink. His career spans positions at leading healthcare and pharmaceutical companies, including Zeon Lifesciences, GSK Pharma, and GSK Consumer Healthcare India.

Read also: Akums Wins 20-Year Patent for Dual Release PPI, Promises Long-Lasting GERD Relief

Akums Drugs & Pharmaceuticals Ltd is a pharmaceutical contract development and manufacturing organization (“CDMO”) offering a comprehensive range of pharmaceutical products and services in India and overseas. The own the intellectual property for the manufacturing processes of several of its formulations, and its core business is focused on providing end-to-end product development and manufacturing solutions to clients. The company has presence in over 60 countries worldwide. Over 12% of all domestically used medications are produced by Akums in almost all therapeutic segments.

akums drugs and pharmaappointmentYuvraj Datta

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751